Search Results - "Shamsaiegahkani, Sahar"

IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer by Yousefi, Hassan, Momeny, Majid, Ghaffari, Seyed H., Parsanejad, Nazanin, Poursheikhani, Arash, Javadikooshesh, Sepehr, Zarrinrad, Ghazaleh, Esmaeili, Fatemeh, Alishahi, Zivar, Sabourinejad, Zahra, Sankanian, Ghazaleh, Shamsaiegahkani, Sahar, Bashash, Davood, Shahsavani, Narjes, Tavakkoly-Bazzaz, Javad, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir

“…Introduction: Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy worldwide and despite an initial response to therapeutic agents, the…”
Get full text

Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cells by Momeny, Majid, Shamsaiegahkani, Sahar, Kashani, Bahareh, Hamzehlou, Sepideh, Esmaeili, Fatemeh, Yousefi, Hassan, Irani, Shiva, Mousavi, Seyed A, Ghaffari, Seyed H

“…Aims Glioblastoma (GB) is the most aggressive type of brain tumor. Rapid progression, active angiogenesis, and therapy resistance are major reasons for its…”
Get full text

Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cells by Momeny, Majid, Shamsaiegahkani, Sahar, Kashani, Bahareh, Hamzehlou, Sepideh, Esmaeili, Fatemeh, Yousefi, Hassan, Irani, Shiva, Mousavi, Seyed A., Ghaffari, Seyed H.

“…Glioblastoma (GB) is the most aggressive type of brain tumor. Rapid progression, active angiogenesis, and therapy resistance are major reasons for its high…”
Get full text

Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells by Momeny, Majid, Yousefi, Hassan, Eyvani, Haniyeh, Moghaddaskho, Farima, Salehi, Ali, Esmaeili, Fatemeh, Alishahi, Zivar, Barghi, Farinaz, Vaezijoze, Somaye, Shamsaiegahkani, Sahar, Zarrinrad, Ghazaleh, Sankanian, Ghazaleh, Sabourinejad, Zahra, Hamzehlou, Sepideh, Bashash, Davood, Aboutorabi, Elaheh S., Ghaffari, Parisa, Dehpour, Ahmad R., Tavangar, Seyyed M., Tavakkoly-Bazzaz, Javad, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H.

“…Epithelial ovarian cancer (EOC) has exhibited marginal improvement in survival rate, despite advances in surgical debulking and chemotherapy regimens. Although…”
Get full text

The effects of Abemaciclib on cell cycle and apoptosis regulation in anaplastic thyroid cancer cells by Abutorabi, Elaheh S., Poursheikhani, Arash, Kashani, Bahareh, Shamsaiegahkani, Sahar, Haghpanah, Vahid, Bashash, Davood, Mousavi, Seied A., Momeny, Majid, Ghaffari, Seyed H.

“…Background: Anaplastic thyroid cancer (ATC) is an aggressive subtype of thyroid cancer, accounting for 1 to 2% of all cases. Deregulations of cell cycle…”
Get full text

Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells by Momeny, Majid, Sankanian, Ghazaleh, Hamzehlou, Sepideh, Yousefi, Hassan, Esmaeili, Fatemeh, Alishahi, Zivar, Karimi, Behnaz, Zandi, Zahra, Shamsaiegahkani, Sahar, Sabourinejad, Zahra, Kashani, Bahareh, Nasrollahzadeh, Ali, Mousavipak, Seyyedeh H., Mousavi, Seyed A., Ghaffari, Seyed H.

“…Prostate Cancer is the second cause of cancer-related death in men and development of metastatic castration-resistant prostate cancer (mCRPC) is the major…”
Get full text